- Investopedia•2 hours ago
Immunomedics sued venBio's board in a dispute concerning its $2 billion deal with Seattle Genetics.
- Accesswire•yesterdaySGEN SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Seattle Genetics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / February 22, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Seattle Genetics, Inc. ("Seattle Genetics" or the "Company") ...
- PR Newswire•yesterdaySGEN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Seattle Genetics Inc. and a Lead Plaintiff Deadline of March 13, 2017
NEW YORK, Feb. 22, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Western District of Washington on behalf of investors ...
SGEN : Summary for Seattle Genetics, Inc. - Yahoo Finance
Seattle Genetics, Inc. (SGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||63.25 x 300|
|Ask||63.28 x 200|
|Day's Range||62.80 - 64.99|
|52 Week Range||29.44 - 75.36|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-62.94|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|